
Sign up to save your podcasts
Or


On this resident blog, PGY-2 SOT Dr. Hannah Roppo joins us from the University of Colorado Hospital to discuss a fresh off-the-press trial exploring conversion from calcineurin inhibitor to belatacept-based maintenance immunosuppression in renal transplant recipients. This blog was precepted by Dr. Barrett Crowther. PMID: 34706967
By The mTOR You Know5
66 ratings
On this resident blog, PGY-2 SOT Dr. Hannah Roppo joins us from the University of Colorado Hospital to discuss a fresh off-the-press trial exploring conversion from calcineurin inhibitor to belatacept-based maintenance immunosuppression in renal transplant recipients. This blog was precepted by Dr. Barrett Crowther. PMID: 34706967

56,921 Listeners

369,752 Listeners

165,240 Listeners

17,912 Listeners

15,344 Listeners